The team also used their human nose organoid model of RSV infection to test the ... infection occurs and provide insights into what would make a person more susceptible to a virus than another.

The team also used their human nose organoid model of RSV infection to test the efficacy of palivizumab, an FDA-approved monoclonal antibody to prevent severe RSV disease in high-risk infants.

The team also used their human nose organoid model of RSV infection to test the efficacy of palivizumab ... control of the infection occurs and provide insights into what would make a person more ...